TTY Biopharm Company Limited (TPEX: 4105)
Taiwan
· Delayed Price · Currency is TWD 73.50
+0.50 (0.68%)
Nov 21, 2024, 12:45 PM CST
TTY Biopharm Company Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5,826 | 5,506 | 5,062 | 4,536 | 4,222 | 4,466 | Upgrade
|
| Revenue Growth (YoY) | 8.03% | 8.77% | 11.60% | 7.43% | -5.47% | 10.66% | Upgrade
|
| Cost of Revenue | 2,420 | 2,218 | 2,040 | 1,768 | 1,617 | 1,559 | Upgrade
|
| Gross Profit | 3,407 | 3,287 | 3,021 | 2,768 | 2,605 | 2,907 | Upgrade
|
| Selling, General & Admin | 1,737 | 1,601 | 1,436 | 1,325 | 1,388 | 1,381 | Upgrade
|
| Research & Development | 327.3 | 310.44 | 353.44 | 287.6 | 261.6 | 298.55 | Upgrade
|
| Other Operating Expenses | 8.3 | 4.95 | 0.38 | 1.43 | -2.28 | 4.86 | Upgrade
|
| Operating Expenses | 2,075 | 1,915 | 1,794 | 1,627 | 1,647 | 1,679 | Upgrade
|
| Operating Income | 1,332 | 1,372 | 1,228 | 1,141 | 957.38 | 1,229 | Upgrade
|
| Interest Expense | -37.34 | -35.18 | -22.85 | -18.97 | -19.41 | -14.81 | Upgrade
|
| Interest & Investment Income | 91.04 | 86.66 | 37.55 | 12.67 | 21.4 | 46.76 | Upgrade
|
| Earnings From Equity Investments | 159.76 | 131.34 | 116.38 | 135.18 | 162.87 | -46.84 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.77 | 0.77 | 23.81 | 1.12 | -15.25 | -11.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 51.75 | 17.29 | 29.5 | -178.39 | 101.01 | 83 | Upgrade
|
| EBT Excluding Unusual Items | 1,598 | 1,573 | 1,412 | 1,092 | 1,208 | 1,286 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -82.69 | Upgrade
|
| Gain (Loss) on Sale of Investments | -35.74 | -35.74 | - | - | -1.56 | 0.38 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.93 | -1.93 | -3.28 | -0.74 | -0.32 | -0.58 | Upgrade
|
| Asset Writedown | -116.18 | -116.18 | -0.73 | -4.15 | -4.58 | - | Upgrade
|
| Pretax Income | 1,444 | 1,419 | 1,408 | 1,087 | 1,202 | 1,203 | Upgrade
|
| Income Tax Expense | 288.05 | 300.86 | 305.25 | 264.81 | 222.85 | 294.95 | Upgrade
|
| Earnings From Continuing Operations | 1,156 | 1,119 | 1,103 | 822.57 | 978.68 | 907.71 | Upgrade
|
| Minority Interest in Earnings | -36.21 | 9.91 | -8.7 | 9.33 | -54.5 | -7.62 | Upgrade
|
| Net Income | 1,120 | 1,129 | 1,094 | 831.89 | 924.18 | 900.08 | Upgrade
|
| Net Income to Common | 1,120 | 1,129 | 1,094 | 831.89 | 924.18 | 900.08 | Upgrade
|
| Net Income Growth | -4.15% | 3.12% | 31.55% | -9.99% | 2.68% | -38.41% | Upgrade
|
| Shares Outstanding (Basic) | 248 | 249 | 249 | 249 | 249 | 249 | Upgrade
|
| Shares Outstanding (Diluted) | 249 | 249 | 249 | 249 | 249 | 249 | Upgrade
|
| Shares Change (YoY) | 0.14% | 0.03% | -0.02% | -0.00% | 0.03% | -0.01% | Upgrade
|
| EPS (Basic) | 4.51 | 4.54 | 4.40 | 3.35 | 3.72 | 3.62 | Upgrade
|
| EPS (Diluted) | 4.49 | 4.53 | 4.40 | 3.34 | 3.71 | 3.61 | Upgrade
|
| EPS Growth | -4.34% | 2.95% | 31.74% | -9.97% | 2.77% | -38.50% | Upgrade
|
| Free Cash Flow | 1,031 | 1,007 | 1,144 | 1,196 | 358.25 | 1,140 | Upgrade
|
| Free Cash Flow Per Share | 4.13 | 4.04 | 4.60 | 4.80 | 1.44 | 4.58 | Upgrade
|
| Dividend Per Share | 3.500 | 3.500 | 3.400 | 3.000 | 4.000 | 4.000 | Upgrade
|
| Dividend Growth | 2.94% | 2.94% | 13.33% | -25.00% | 0% | -11.11% | Upgrade
|
| Gross Margin | 58.47% | 59.70% | 59.69% | 61.03% | 61.70% | 65.09% | Upgrade
|
| Operating Margin | 22.86% | 24.93% | 24.26% | 25.15% | 22.68% | 27.51% | Upgrade
|
| Profit Margin | 19.22% | 20.50% | 21.62% | 18.34% | 21.89% | 20.15% | Upgrade
|
| Free Cash Flow Margin | 17.69% | 18.29% | 22.61% | 26.37% | 8.49% | 25.52% | Upgrade
|
| EBITDA | 1,519 | 1,566 | 1,409 | 1,303 | 1,111 | 1,377 | Upgrade
|
| EBITDA Margin | 26.07% | 28.44% | 27.83% | 28.74% | 26.32% | 30.83% | Upgrade
|
| D&A For EBITDA | 186.82 | 193.1 | 180.69 | 162.79 | 153.86 | 148.56 | Upgrade
|
| EBIT | 1,332 | 1,372 | 1,228 | 1,141 | 957.38 | 1,229 | Upgrade
|
| EBIT Margin | 22.86% | 24.93% | 24.26% | 25.15% | 22.68% | 27.51% | Upgrade
|
| Effective Tax Rate | 19.95% | 21.20% | 21.67% | 24.35% | 18.55% | 24.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.